U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07321288) titled 'Machine Learning-Based Prediction of Insulin Resistance in Psoriasis Patients Emphasizing Interpretability' on Dec. 22, 2025.
Brief Summary: Psoriasis is a long-term inflammatory skin disease that can affect overall health. People with psoriasis have a higher risk of developing insulin resistance, a condition in which the body does not respond properly to insulin. Insulin resistance can increase the risk of diabetes, heart disease, and other serious health problems. Because insulin resistance often develops without clear symptoms, many patients are not diagnosed early.
The purpose of this study is to identify which patients with pso...